Nautilus Biotechnology, Inc. (NAUT)
NASDAQ
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
2.5752 wk Range
0.8410Profile - NAUT - Nautilus Biotechnology, Inc.
Profile
Mic Code
XNGS
Sector
Healthcare
Industry
Biotechnology
Employees
127
Nautilus Biotechnology, Inc. is a life sciences company focused on proteomics, the large-scale study of proteins and their functions. Nautilus Biotechnology develops a platform technology designed to quantify and analyze the human proteome with high resolution, combining instrumentation, consumables, software, and analysis tools into an integrated workflow. Its current products and systems support single-molecule protein analysis and multi-cycle proteome mapping, serving research-oriented markets in biotechnology, pharmaceuticals, and academic science. The company’s platform is intended to help scientists examine protein complexity more deeply, supporting applications in biomedical research, disease biology, and drug discovery. Headquartered in Seattle, Washington, with research and development operations in San Carlos, California, Nautilus Biotechnology operates as a development-stage company in the life sciences tools segment.
Profile Details
Type
Common Stock
Address
2701 Eastlake Avenue East
City
Seattle
State
WA
Zip
98102
Country
United States
Phone
206 333 2001
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
